Clinical Trial Update: IdB 1016 Treatment for Hepatitis C Disease [Phase 1, Phase 2]

View source ↗

Summary

This update reports on the completed Phase 1/2 clinical trial of IdB 1016 for chronic hepatitis C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• IdB 1016

Snippet

Sponsor: National Center for Complementary and Integrative Health (NCCIH) | Conditions: Hepatitis C, Chronic | Phase 1, Phase 2 | Status: COMPLETED